Indications and Purposes
| 1 Indications And Usage Strensiq ® Is Indicated For The Treatment Of Patients With Perinatal/infantile- And Juvenile-Onset Hypophosphatasia (Hpp). Strensiq Is A Tissue Nonspecific Alkaline Phosphatase Indicated For The Treatment Of Patients With Perinatal/infantile- And Juvenile-Onset Hypophosphatasia (Hpp). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Asfotase Alfa |